SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jampol LM, Sieving PA, Pugh D, Fishman GA, Gilbert H. Multiple evanescent white dot syndrome. I. Clinical findings. Arch Ophthalmol 1984; 102: 671674.
  • 2
    Sieving PA, Fishman GA, Jampol LM, Pugh D. Multiple evanescent white dot syndrome. II. Electrophysiology of the photoreceptors during retinal pigment epithelial disease. Arch Ophthalmol 1984; 102: 675679.
  • 3
    Ie D, Glaser BM, Murphy RP, Gordon LW, Sjaarda RN, Thompson JT. Indocyanine green angiography in multiple evanescent white-dot syndrome. Am J Ophthalmol 1994; 117: 712.
  • 4
    Gross NE, Yannuzzi LA, Freund KB, Spaide RF, Amato GP, Sigal R. Multiple evanescent white dot syndrome. Arch Ophthalmol 2006; 124: 493500.
  • 5
    Laatikainen L, Immonen I. Multiple evanescent white dot syndrome. Graefes Arch Clin Exp Ophthalmol 1988; 226: 3740.
  • 6
    Feigl B, Haas A, El-Shabrawi Y. Multifocal ERG in multiple evanescent white dot syndrome. Graefes Arch Clin Exp Ophthalmol 2002; 240: 615621.
  • 7
    Li D, Kishi S. Restored photoreceptor outer segment damage in multiple evanescent white dot syndrome. Ophthalmology 2009; 116: 762770.
  • 8
    Nguyen MH, Witkin AJ, Reichel E, Ko TH, Fujimoto JG, Schuman JS, Duker JS. Microstructural abnormalities in MEWDS demonstrated by ultrahigh resolution optical coherence tomography. Retina 2007; 27: 414418.
  • 9
    Hangai M, Fujimoto M, Yoshimura N. Features and function of multiple evanescent white dot syndrome. Arch Ophthalmol 2009; 127: 13071313.
  • 10
    Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol 2010; 150: 325329.
  • 11
    Herbort CP. Inflammatory choriocapillaropathies: general concepts. In: Gupta A, Gupta G, Herbort CP, Khairallah M, eds. Uveitis Text and Imaging. New Delhi: Jaypee Brothers Medical Publishers, 2009. p 430441.
  • 12
    Herbort CP. Multiple evanescent white dot syndrome (MEWDS) and acute idiopathic blind spot enlargement (AIBSE). In: Gupta A, Gupta G, Herbort CP, Khairallah M, eds. Uveitis Text and Imaging. New Delhi: Jaypee Brothers Medical Publishers, 2009. p 441447.
  • 13
    Schaal S, Schiff WM, Kaplan HJ, Tezel TH. Simultaneous appearance of multiple evanescent white dot syndrome and multifocal choroiditis indicate a common causal relationship. Ocul Immunol Inflamm 2009; 17: 325327.
  • 14
    Maruko I, Iida T, Sugano Y, Oyamada H, Sekiryu T, Fujiwara T, Spaide RF. Subfoveal choroidal thickness after treatment of Vogt–Koyanagi–Harada disease. Retina 2011; 31: 510517.
  • 15
    Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009; 29: 14691473.
  • 16
    Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 2010; 117: 17921799.
  • 17
    Bouchenaki N, Herbort CP. Stromal choroiditis.In: Pleyer U, Mondino B, eds. Uveitis and Immunological Disorders. Berlin: Springer, 2004. p 233253.
  • 18
    Klais CM, Ober MD, Ciardella AP, Yannuzzi LA. Central serous chorioretinopathy. In: Ryan SJ, ed. Retina. 4th ed. Vol 2. Philadelphia: Elsevier Mosby, 2006. p 11351161.
  • 19
    Tsai LM, Jampol LM. Multiple evanescent white-dot syndrome. In: Ryan SJ, ed. Retina. 4th ed. Vol 2. Philadelphia: Elsevier Mosby, 2006. p 17851791.
  • 20
    Sikorski BL, Wojtkowski M, Kaluzny JJ, Szkulmowski M, Kowalczyk A. Correlation of spectral optical coherence tomography with fluorescein and indocyanine green angiography in multiple evanescent white dot syndrome. Br J Ophthalmol 2008; 92: 15521557.
  • 21
    Diomede L, Albani D, Sottocorno M, Donati MB, Bianchi M, Fruscella P, Salmona M. In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler Thromb Vasc Biol 2001; 21: 13271332.
  • 22
    Bartoli M, Al-Shabrawey M, Labazi M, Behzadian MA, Istanboli M, El-Remessy AB, Cardwell AW et al. HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 2009; 50: 49344940.